Format

Send to

Choose Destination
CNS Neurosci Ther. 2014 Jul;20(7):582-90. doi: 10.1111/cns.12247.

Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.

Author information

1
Department of Behavioral Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, Russia.

Abstract

Serotonin (5-hydroxytryptamine or 5-HT) is an important neurotransmitter regulating a wide range of physiological and pathological functions via activation of heterogeneously expressed 5-HT receptors. Besides the important role of 5-HT receptors in the pathogenesis of depressive disorders and in their clinical medications, underlying mechanisms are far from being completely understood. This review focuses on possible cross talk between two serotonin receptors, 5-HT1A and the 5-HT7 . Although these receptors are highly co-expressed in brain regions implicated in depression, and most agonists developed for the 5-HT1A or 5-HT7 receptors have cross-reactivity, their functional interaction has not been yet established. It has been recently shown that 5-HT1A and 5-HT7 receptors form homo- and heterodimers both in vitro and in vivo. From the functional point of view, heterodimerization has been shown to play an important role in regulation of receptor-mediated signaling and internalization, suggesting the implication of heterodimerization in the development and maintenance of depression. Interaction between these receptors is also of clinical interest, because both receptors represent an important pharmacological target for the treatment of depression and anxiety.

KEYWORDS:

5-HT1A/5-HT7 receptor cross talk; Depression; G protein-coupled receptor (GPCR); Receptor dimerization; Serotonin

PMID:
24935787
DOI:
10.1111/cns.12247
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center